FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Alzheimer's

Animal data supports J&J;'s Alzheimer's vaccine

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


J&J's Alzheimer's research group at Janssen has found positive signs for bapineuzumab, its late-stage Alzheimer's therapeutic vaccine. In a study using mice, researchers found that those who were inoculated performed a simple task more effectively, which could mean the vax was successful at stopping amyloid plaque from binding with neurons. Story

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Alzheimer's  


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.